真實世界證據解決方案市場規模、佔有率、收益分析，按組件、按應用、按收益模式、按部署模式、按最終用戶、按地區 - 行業預測，2024-2031 年

真實世界證據解決方案的全球市場規模預計到2022 年為15.4 億美元，從2023 年的18 億美元成長到2031 年的62.6 億美元，預測期（2024-2031 年）預計將以16.9% 的年複合成長率成長。

真實世界證據 (RWE) 解決方案市場專注於使用真實環境中的資料來支援臨床決策、監管核准和健康結果研究。由於對循證醫學的需求不斷成長以及對具有成本效益的醫療保健解決方案的需求，該市場正在經歷顯著成長。 RWE 解決方案利用電子健康記錄、保險申請和病患登記的大型資料集集來產生見解，幫助了解治療效果、安全概況和病患結果。由於慢性病的增加和對個人化醫療的日益重視，市場正在迅速擴大。資料分析的技術進步和相關人員之間日益加強的合作也推動了市場的成長。

目錄

介紹

• 研究目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 二手資料來源和主要資料來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 價值鏈分析
• 價格分析
• 技術分析
• 關稅和監管狀況
• 專利分析
• 客戶和購買標準分析

真實世界證據解決方案市場：按組成部分

• 市場概況
• 服務
• 資料集
  • 異質資料集集
  • 臨床設置資料集
  • 索賠資料集集
  • 藥房資料集
  • 患者主導的資料集
  • 基於註冊表的資料集
  • 綜合資料集集

真實世界證據解決方案市場：按應用分類

• 市場概況
• 藥物研發及核准
  • 腫瘤學
  • 心血管疾病
  • 神經病學
  • 免疫學
  • 其他治療領域
• 醫療設備開發及核准
• 上市後監測
• 市場進入和報銷/覆蓋決策
• 臨床和監管決策

真實世界證據解決方案市場：按收益模式分類

• 市場概況
• 付費使用制（基於價值的定價）
• 訂閱

真實世界證據解決方案市場：依部署模式

• 市場概況
• 本地
• 雲端基礎

真實世界證據解決方案市場：按最終用戶分類

• 市場概況
• 製藥和醫療設備公司
• 醫療保健付款人
• 醫療服務提供方
• 其他最終用戶

真實世界證據解決方案市場：按地區分類的規模

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• Merative
• Icon Plc
• Parexel International Corporation
• Oracle Corporation
• Trinetx Llc
• Trinity
• Cognizant Technology Solutions Corporation
• Cegedim Health Data
• Verantos
• Datavant
• Tempus
• Flatiron Health
• Quantzig

Global Real-World Evidence Solutions Market size was valued at USD 1.54 billion in 2022 and is poised to grow from USD 1.80 billion in 2023 to USD 6.26 billion by 2031, growing at a CAGR of 16.9% in the forecast period (2024-2031).

Real-World Evidence (RWE) Solutions Market focuses on the use of data from real-world settings to support clinical decision-making, regulatory approvals, and health outcomes research. This market has experienced substantial growth due to the increasing demand for evidence-based medicine and the need for cost-effective healthcare solutions. RWE solutions leverage large datasets from electronic health records, insurance claims, and patient registries to generate insights that help in understanding treatment effectiveness, safety profiles, and patient outcomes. With the rise in chronic diseases and the growing emphasis on personalized medicine, the market is expanding rapidly. Technological advancements in data analytics and an increasing number of collaborations between stakeholders are also fueling market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Real-World Evidence Solutions Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Real-World Evidence Solutions Market Segmental Analysis

Global Real-World Evidence Solutions Market is segmented on the basis of component, application, revenue model, end user, and region. By component, market is segmented into services, and data sets. By application, market is segmented into drug development & approvals, medical device development & approvals, post-market surveillance, market access & reimbursement/coverage decision-making, and clinical & regulatory decision-making. By revenue model, market is segmented into, pay per use (value-based pricing), and subscription. By deployment mode, market is segmented into on-premise, and cloud-based. By end user, market is segmented into pharmaceutical & medical device companies, healthcare payers, healthcare providers, and other end users. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Real-World Evidence Solutions Market

One significant driver of the RWE Solutions Market is the growing demand for personalized medicine. Personalized medicine aims to tailor treatments to individual patient profiles, including genetic, environmental, and lifestyle factors. This approach relies heavily on real-world evidence to validate and optimize personalized treatment strategies. RWE provides insights into how different patient populations respond to treatments in real-world settings, enabling more accurate predictions of efficacy and safety. For instance, pharmaceutical companies utilize RWE to identify patient subgroups that may benefit most from specific therapies, leading to more targeted and effective interventions. As personalized medicine continues to evolve, the need for comprehensive real-world data to support these strategies drives demand for advanced RWE solutions.

Restraints in the Real-World Evidence Solutions Market

A major restraint in the RWE Solutions Market is the growing concern over data privacy and security. Real-world data, including sensitive health information, raises significant privacy issues and regulatory challenges. Stringent data protection regulations, such as the General Data Protection Regulation (GDPR) in Europe and the Health Insurance Portability and Accountability Act (HIPAA) in the US, impose strict requirements on data handling, storage, and sharing. Compliance with these regulations can be complex and costly for organizations seeking to leverage real-world data. Additionally, breaches of data security can lead to severe legal and reputational consequences. Addressing these privacy concerns while ensuring data integrity and security remains a critical challenge for stakeholders in the RWE solutions market.

Market Trends of the Real-World Evidence Solutions Market

A prominent trend in the RWE Solutions Market is the increasing integration of artificial intelligence (AI) and machine learning (ML) technologies. AI and ML enhance the capability to analyze and interpret large volumes of real-world data, uncovering patterns and insights that might not be evident through traditional methods. These technologies facilitate advanced data analytics, enabling more accurate predictions of treatment outcomes, identification of new biomarkers, and optimization of clinical trial designs. For example, AI-driven algorithms can predict patient responses to treatments based on historical data, helping to personalize healthcare strategies and improve patient outcomes. The growing adoption of AI and ML is transforming the RWE landscape, making data analysis more efficient and actionable, and driving innovation across the healthcare industry.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Tariff And Regulatory Landscape
• Patent Analysis
• Customer & Buying Criteria Analysis

Real-World Evidence Solutions Market, By Component

• Market Overview
• Services
• Data Sets
  • Disparate Data Sets
  • Clinical Settings Data Sets
  • Claims Data Sets
  • Pharmacy Data Sets
  • Patient-Powered Data Sets
  • Registry-Based Data Sets
  • Integrated Data Sets

Real-World Evidence Solutions Market, By Application

• Market Overview
• Drug Development & Approvals
  • Oncology
  • Cardiovascular Disease
  • Neurology
  • Immunology
  • Other Therapeutic Areas
• Medical Device Development & Approvals
• Post-Market Surveillance
• Market Access & Reimbursement/Coverage Decision-Making
• Clinical & Regulatory Decision-Making

Real-World Evidence Solutions Market, By Revenue Model

• Market Overview
• Pay Per Use (Value-Based Pricing)
• Subscription

Real-World Evidence Solutions Market, By Deployment Mode

• Market Overview
• On-Premise
• Cloud-Based

Real-World Evidence Solutions Market, By End User

• Market Overview
• Pharmaceutical & Medical Device Companies
• Healthcare Payers
• Healthcare Providers
• Other End Users

Real-World Evidence Solutions Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Merative
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Icon Plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parexel International Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oracle Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trinetx Llc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trinity
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cognizant Technology Solutions Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cegedim Health Data
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Verantos
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Datavant
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tempus
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Flatiron Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quantzig
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments